Results 101 to 110 of about 121,700,018 (217)

Botulinum toxin type A for the management of glabellar rhytids [PDF]

, 2010
Anne Marie Tremaine, Jerry L McCulloughDepartment of Dermatology, University of California, Irvine, CA, USAAbstract: There is an increasing demand for minimally-invasive cosmetic procedures to arrest the aging process.
Tremaine, Anne Marie, Anne Marie Tremaine, McCullough, Jerry L, Jerry L McCullough   +3 more
core   +1 more source

An Open Study of Botulinum-A Toxin Treatment of Idiopathic Trigeminal Neuralgia [PDF]

Patient Safety and Quality Improvement Journal, 2015
Introduction: Trigeminal Neuralgia (TN) is a unilateral, recurrent, sharp facial pain disorder that is limited to the distribution of divisions of the trigeminal nerve.
Karim Nikkhah, Mohammad Taghi Farzadfard, Payam Sasannejad, Ali Ghabeli Juibary, Marzieh Taheri, Samira Aminzadeh   +5 more
doaj  

What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection

, 2009
PURPOSE: We documented the effects of intradetrusor injections of botulinum neurotoxin type A (Botox(R)) for refractory idiopathic detrusor overactivity so that prospective patients maybe properly informed about possible improvement in quality of life ...
Panicker, Jalesh, Khan, Shahid, Kalsi, Vinay, Kessler, Thomas M, Dasgupta, Prokar, Fowler, Clare J, Elneil, Sohier, Haslam, Collete, Roosen, Alexander, Apostolidis, Apostolos, Gonzales, Gwen, Kessler, Thomas M.   +11 more
core   +1 more source

RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxin [PDF]

, 2013
A surface plasmon resonance based RNA aptasensor for rapid detection of natively folded type A botulinum neurotoxin is reported. Using detoxified recombinant type A botulinum neurotoxin as the surrogate, the aptasensor detects active toxin within 90 min.
Janardhanan, Pavithra, Lou, Jianlong, Marks, James D, Cai, Shuowei, Singh, Bal Ram, Mello, Charlene M   +5 more
core   +1 more source

Effects of Carbon Dioxide on Neurotoxin Gene Expression in Non-proteolytic Clostridium botulinum type E.

, 2008
Carbon dioxide is an antimicrobial gas commonly used in modified atmosphere packaging. In the present study, the effects of carbon dioxide on growth of, and neurotoxin production by, non-proteolytic Clostridium botulinum type E were studied during the ...
Carter, Andrew T, Holst, Elisabet,, Mason, David R, Artin, Ingrid, Rådström, Peter, Lövenklev, Maria, Holst, Elisabet, Artin, Ingrid,, Lund University., Peck, Michael W, Lövenklev, Maria,, Artin, I., Peck, M.W., Carter, A.T., Holst, Emma,, Mason, D.R.   +15 more
core   +2 more sources

Machine learning-based typing of Clostridium botulinum group III by FT-IR spectroscopy

Microbiology Spectrum
This study aimed to investigate the utility of Fourier-Transform Infrared Spectroscopy (FT-IRS) for differentiating Clostridium botulinum (C. botulinum) based on its botulinum neurotoxin (BoNT)-encoding gene type and its potential as an epidemiological ...
Ilenia Drigo, Angela Guolo, Alessia Rizzardi, Miriam Cordovana, Manuel Garbuio, Elena Tonon, Marco Vedana, Luca Zandonà, Luca Bano   +8 more
doaj   +1 more source

Detection of Clostridium Botulinum Neurotoxin Type a Using Immuno-Pcr

, 2008
AIMS: An immuno-polymerase chain reaction (immuno-PCR) has been developed for the sensitive detection of antigens, which greatly extends the detection limits of immunoassays.
WU, HAN-CHUNG;SHAIO, MEN-FANG, 吳漢忠;蕭孟芳   +1 more
core  

Detection of the genes encoding botulinum neurotoxin types A to E by the polymerase chain reaction

, 1993
The polymerase chain reaction (PCR) was used as the basis for the development of highly sensitive and specific diagnostic tests for organisms harboring botulinum neurotoxin type A through E genes.
Szabo, E. A., Pemberton, J. M., Desmarchelier, P. M.   +2 more
core   +1 more source

Botulinum neurotoxin type A combined with functional electrical stimulation for upper-limb poststroke spasticity with pain

, 2018
Stroke is a complicated condition that leaves stroke survivors with prolonged disability. Common poststroke conditions are spasticity and pain, which directly affect daily activities and quality of life in these patients.
Nikbakht, Anahita, Gazerani, Parisa; id_orcid, Karshenas, Ali   +2 more
core   +1 more source

The Effect of Different Doses of Botulinum Toxin on Masseter Muscle in Patients with Bruxism.

Erbil Dental Journal, 2022
Background and Objectives: Botulinum toxin type A is produced by clostridium botulinum. It acts by inhibiting the release of acetylcholine from cholinergic neurons.
Kawa F. Dizaye, Sarezh Jamal Jalal
doaj